financetom
Business
financetom
/
Business
/
Lululemon Lifts Full-Year Earnings Outlook After Fiscal First-Quarter Beat; Stock Jumps After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lululemon Lifts Full-Year Earnings Outlook After Fiscal First-Quarter Beat; Stock Jumps After Hours
Jun 5, 2024 1:52 PM

04:43 PM EDT, 06/05/2024 (MT Newswires) -- Lululemon Athletica ( LULU ) late Wednesday reported stronger-than-expected fiscal first-quarter results while the athletic apparel and footwear company lifted its full-year earnings outlook.

Earnings advanced to $2.54 a share during the quarter through April 28 from $2.28 the year before, surpassing the Capital IQ-polled GAAP consensus of $2.42. Revenue increased 10% to $2.21 billion, just above analysts' $2.2 billion estimate.

Lululemon's Nasdaq-listed stock was rallying 13% in after-hours trade.

Comparable sales increased 6%, driven by a 25% jump in international operations. The consensus was for a 6.5% headline rise.

Lululemon expects full-year EPS of $14.27 to $14.47, compared with $14 to $14.20 previously projected. The company continues to expect revenue of $10.7 billion to $10.8 billion. Analysts are forecasting GAAP EPS of $14.18 and sales of $10.76 billion.

For the fiscal second quarter, the company expects EPS of $2.92 to $2.97 on revenue between $2.4 billion to $2.42 billion. The Street is looking for $3.06 and $2.45 billion, respectively.

Lululemon's board on May 29 approved a $1 billion increase to the company's stock repurchase program, bringing its remaining authorized amount to about $1.7 billion as of Wednesday.

Price: 346.40, Change: +38.13, Percent Change: +12.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Powell Asks for Internal Review of $2.5 Billion Headquarters Renovation
Market Chatter: Powell Asks for Internal Review of $2.5 Billion Headquarters Renovation
Jul 14, 2025
10:06 AM EDT, 07/14/2025 (MT Newswires) -- Federal Reserve Chair Jerome Powell asked the central bank's inspector general to review its $2.5 billion headquarters renovation project, Axios reported Monday, citing a source. The Fed did not immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Matador Technologies Files Preliminary Base Shelf Prospectus for $900 Million
Matador Technologies Files Preliminary Base Shelf Prospectus for $900 Million
Jul 14, 2025
10:06 AM EDT, 07/14/2025 (MT Newswires) -- Matador Technologies ( MATAF ) on Monday said it filed a preliminary short form base shelf prospectus for up to $900 million with the securities commissions in all Canadian provinces except Quebec. If approved by regulators, the shelf prospectus will allow the company to issue over a 25-month period up to $900 million...
BiomX Doses First Patient in Phase 2b of Cystic Fibrosis Trial
BiomX Doses First Patient in Phase 2b of Cystic Fibrosis Trial
Jul 14, 2025
10:08 AM EDT, 07/14/2025 (MT Newswires) -- BiomX Inc. ( PHGE ) said Monday that it has successfully dosed its first patient as part of its phase 2b trial evaluating BX004 for the treatment of cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa infections. Topline results from the study are expected in Q1 2026, the company said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved